Epitomee slumps as Nestle nixes marketing weight loss pill
Israeli ingestible medical devices company Epitomee Medical (TASE: EPIT) notified the Tel Aviv Stock Exchange (TASE) this morning that its planned marketing partner Nestlé has announced that the clinical trial results of…
